Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. News
  7. Summary
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Khiron Life Sciences Corp.: Invitation to the Benzinga Virtual Cannabis Capital Conference

02/22/2021 | 09:35am EDT

Detroit, Michigan--(Newsfile Corp. - February 22, 2021) - Khiron Life Sciences Corp. (TSXV: KHRN) will be presenting at the Benzinga Cannabis Capital Conference taking place on February 25-26, 2021. We invite our shareholder and all interested parties to join us for a full day of networking, dealmaking and discovery. Sign up to get a free spectator pass for the event: https://events.benzinga.com/ccc-free-registration.

About Benzinga Cannabis Capital Conference

Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe.

For more information and/or to register for the conference please visit: https://events.benzinga.com/ccc-free-registration.

We look forward to seeing you there.

For further information:

Khiron Life Sciences Corp.
Paola Ricardo
(647) 556-5750
investors@khiron.ca
https://investors.khiron.ca/corporate-information


© Newsfilecorp 2021
All news about KHIRON LIFE SCIENCES CORP.
09/13KHIRON LIFE SCIENCES : Renews Normal Course Issuer Bid
MT
09/09KHIRON LIFE SCIENCES : Announces Intention to Renew Normal Course Issuer Bid
MT
09/09Khiron Life Sciences Corp. announces an Equity Buyback for 8,955,893 shares, ..
CI
09/09Khiron Life Sciences Corp. authorizes a Buyback Plan.
CI
08/31KHIRON LIFE SCIENCES : Registers First Medical Cannabis Products in Peru
MT
08/31KHIRON LIFE SCIENCES : Registers its First Two Medical Cannabis Products in Peru..
PR
08/31Khiron Registers its First Two Medical Cannabis Products in Peru
CI
08/23KHIRON LIFE SCIENCES : Books Q2 Loss of C$0.03 per Share, Expects Medical Cannab..
MT
08/23Khiron Life Sciences Corp. Reports Earnings Results for the Second Quarter En..
CI
08/11KHIRON LIFE SCIENCES CORP. : Invitation to the Q3 Virtual Investor Summit
NE
More news
Financials
Sales 2021 13,0 M 10,2 M 10,2 M
Net income 2021 -22,2 M -17,4 M -17,4 M
Net Debt 2021 15,0 M 11,7 M 11,7 M
P/E ratio 2021 -1,40x
Yield 2021 -
Capitalization 50,2 M 39,3 M 39,2 M
EV / Sales 2021 5,01x
EV / Sales 2022 2,23x
Nbr of Employees -
Free-Float 94,7%
Chart KHIRON LIFE SCIENCES CORP.
Duration : Period :
Khiron Life Sciences Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KHIRON LIFE SCIENCES CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,28 CAD
Average target price 0,85 CAD
Spread / Average Target 204%
EPS Revisions
Managers and Directors
Álvaro F. Torres Chief Executive Officer & Director
Joel Friedman Chief Financial Officer
Chris Naprawa Chairman
Jairo Espinoza Vice President-Medical Affairs
Manuel Buendia Vice President-Operations
Sector and Competitors